Michigan Medicine has developed a new technique that provides a non-invasive alternative to surgery, chemotherapy and radiation treatments for cancer.

Molecular changes in nonalcoholic fatty liver disease could serve as potential therapeutic targets to halt the cells’ progression to liver cancer.

Crohn’s disease, FODMAP, SUN1 gene and more: Research updates from Michigan Medicine clinicians.

Ultrasound technology has been repurposed as a technique to treat liver tumors in rats.

Trial will evaluate the safety and efficacy of histotripsy against liver tumors at eight U.S. sites

A pregnant liver transplant recipient receives cutting-edge monoclonal antibody treatment for COVID-19 months before her due date.

From early stage colon cancer to advanced metastatic disease, Jennifer Watson’s cancer journey illustrates the importance of advocating for your health and partnering with a care team you trust.

The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.

A hepatologist comments on the new USPSTF guidelines for detecting hepatitis B in non-pregnant adults and adolescents. 

A liver transplant recipient spends 40 days in the ICU at Michigan Medicine and recovers. He shares how his wife and a familiar doctor helped him survive.

One liver transplant cured a patient of three chronic conditions: liver cancer, hepatitis C and hemophilia.

Michigan Medicine researchers have advanced the global fight to eliminate hepatitis C by creating a barrier-breaking reliable, low-cost and scalable test for HCV.

Study finds liver damage more commonly due to malignant tumors than cancer immunotherapy drug.

U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.

A cutting-edge imaging strategy could significantly improve survival rates among patients at risk for liver cancer.